Pharmaceutics (Oct 2021)

Advances of Nanomedicine in Radiotherapy

  • Wei Liu,
  • Bo Chen,
  • Haocheng Zheng,
  • Yun Xing,
  • Guiyuan Chen,
  • Peijie Zhou,
  • Liting Qian,
  • Yuanzeng Min

DOI
https://doi.org/10.3390/pharmaceutics13111757
Journal volume & issue
Vol. 13, no. 11
p. 1757

Abstract

Read online

Radiotherapy (RT) remains one of the current main treatment strategies for many types of cancer. However, how to improve RT efficiency while reducing its side effects is still a large challenge to be overcome. Advancements in nanomedicine have provided many effective approaches for radiosensitization. Metal nanoparticles (NPs) such as platinum-based or hafnium-based NPs are proved to be ideal radiosensitizers because of their unique physicochemical properties and high X-ray absorption efficiency. With nanoparticles, such as liposomes, bovine serum albumin, and polymers, the radiosensitizing drugs can be promoted to reach the tumor sites, thereby enhancing anti-tumor responses. Nowadays, the combination of some NPs and RT have been applied to clinical treatment for many types of cancer, including breast cancer. Here, as well as reviewing recent studies on radiotherapy combined with inorganic, organic, and biomimetic nanomaterials for oncology, we analyzed the underlying mechanisms of NPs radiosensitization, which may contribute to exploring new directions for the clinical translation of nanoparticle-based radiosensitizers.

Keywords